3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
28
Colorectal Neoplasms
24
Colonic Neoplasms
16
Pancreatic Neoplasms
11
Neoplasms
11
Rectal Neoplasms
10
Breast Neoplasms
9
Stomach Neoplasms
7
Esophageal Neoplasms
6
Prostatic Neoplasms
4
Lung Neoplasms
3
Liver Neoplasms
3
Postoperative Complications
2
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Disease
2
Weight Loss
1
Urinary Incontinence
1
Thyroid Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Risk Reduction Behavior
1
Psychological Well-Being
1
Peripheral Nervous System Diseases
1
Patient Compliance
1
Pancreas Adenocarcinoma
1
Obesity
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma
1
Interventions
Surveys and Questionnaires
2
bemarituzumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Leucovorin
1
Lapatinib
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Exercise
1
Diet Therapy
1
Carboplatin
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
GastroEsophageal Cancer
×
Exercise
×
Gastrointestinal
×
Clear all
NCT03490565
2023-06-22
PRESET-RCT
Rigshospitalet, Denmark
Phase NA
Active not recruiting
310 enrolled